Mirae Asset Global Investments’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.57M Sell
12,513
-1,064
-8% -$134K 0.01% 752
2025
Q1
$1.52M Sell
13,577
-2,781
-17% -$311K 0.01% 744
2024
Q4
$2.25M Buy
16,358
+2,925
+22% +$402K 0.01% 628
2024
Q3
$1.55M Buy
13,433
+9,601
+251% +$1.1M 0.01% 710
2024
Q2
$515K Sell
3,832
-9,468
-71% -$1.27M ﹤0.01% 918
2024
Q1
$1.52M Sell
13,300
-13,688
-51% -$1.56M ﹤0.01% 1336
2023
Q4
$3.56M Sell
26,988
-2,074
-7% -$274K 0.01% 1020
2023
Q3
$3.3M Sell
29,062
-6,502
-18% -$738K 0.01% 986
2023
Q2
$3.36M Sell
35,564
-3,729
-9% -$352K 0.01% 1008
2023
Q1
$3.94M Buy
39,293
+12,663
+48% +$1.27M 0.01% 934
2022
Q4
$3.19M Sell
26,630
-5,889
-18% -$706K 0.01% 953
2022
Q3
$3.39M Sell
32,519
-4,613
-12% -$481K 0.01% 938
2022
Q2
$3.62M Sell
37,132
-1,310
-3% -$128K 0.01% 938
2022
Q1
$3.61M Sell
38,442
-5,064
-12% -$475K 0.01% 973
2021
Q4
$3.69M Sell
43,506
-2,681
-6% -$228K 0.01% 967
2021
Q3
$4.43M Buy
46,187
+5,642
+14% +$541K 0.01% 877
2021
Q2
$3.95M Sell
40,545
-1,105
-3% -$108K 0.01% 871
2021
Q1
$4.05M Sell
41,650
-9,705
-19% -$944K 0.01% 777
2020
Q4
$4.92M Buy
51,355
+11,726
+30% +$1.12M 0.02% 656
2020
Q3
$3.83M Buy
39,629
+1,186
+3% +$115K 0.02% 605
2020
Q2
$4.69M Sell
38,443
-7,806
-17% -$952K 0.03% 519
2020
Q1
$4M Sell
46,249
-193,081
-81% -$16.7M 0.03% 484
2019
Q4
$25.7M Sell
239,330
-6,554
-3% -$705K 0.16% 148
2019
Q3
$22.2M Sell
245,884
-56,650
-19% -$5.1M 0.15% 161
2019
Q2
$25.5M Sell
302,534
-3,799
-1% -$321K 0.17% 129
2019
Q1
$27M Buy
306,333
+40,572
+15% +$3.57M 0.2% 114
2018
Q4
$19M Buy
265,761
+15,861
+6% +$1.13M 0.17% 133
2018
Q3
$30.7M Buy
249,900
+164,306
+192% +$20.2M 0.23% 101
2018
Q2
$8.41M Buy
85,594
+5,302
+7% +$521K 0.11% 122
2018
Q1
$6.66M Buy
80,292
+26,930
+50% +$2.23M 0.09% 148
2017
Q4
$4.14M Buy
53,362
+37,690
+240% +$2.92M 0.06% 215
2017
Q3
$961K Buy
+15,672
New +$961K 0.02% 431